분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-08-03 16:50:33 , Hit : 1221
 “Kissing Disease” Virus Promotes Malignant Breast Cancer Development

GEN News Highlights
More »
Aug 2, 2016


Researchers have found that infection with the Epstein-Barr virus (pictured) may put some women at increased risk for developing breast cancer. [NIH]


In our adolescent years, we would often snicker at other kids who were diagnosed with mononucleosis, as it was (and often still is) colloquially referred to as the “kissing disease.” However, in recent years mounting evidence has suggested that infection with Epstein-Barr virus (EBV) has become associated with various forms of cancer—which is certainly no laughing matter.

Alarmingly, a new study led by researchers from the Beth Israel Deaconess Medical Center (BIDMC) has revealed that infection with EBV may put some women at increased risk of developing breast cancer. Yet, results from the new study—“Epstein–Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation”—published recently in EBioMedicine, may provide important implications for breast cancer screening and prevention in the future.

EBV, one of eight known viruses in the herpes family (human herpes 4 or HHV4) to infect humans, is also one of the most common viruses to infect humans and is best known as the cause of infectious mononucleosis. Although more than 90% of the world's population carries EBV, most individuals experience no effects from infection. Nonetheless, in certain individuals, EBV has been linked to various cancers, including African Burkitt's lymphoma, Hodgkin's disease, nasopharyngeal carcinoma, gastric adenocarcinoma, and leiomyosarcoma.

Some more recent studies have tied EBV infection to breast cancer, yet it's unclear how the virus may play a role in breast cancer development and/or progression. To investigate EBV’s role in breast cancer development, researchers cultured breast cells called primary mammary epithelial cells (MECs) in the presence of the virus.

The authors wrote that "EBV can infect primary MECs that express the receptor CD21. EBV infection leads to the expansion of early MEC progenitor cells with a stem cell phenotype, activates MET signaling and enforces a differentiation block. When MECs were implanted as xenografts, EBV infection cooperated with activated Ras and accelerated the formation of breast cancer.”

Interestingly, when the investigators subsequently analyzed the genes of MECs infected with EBV, they found genetic characteristics associated with high-grade, estrogen-receptor-negative breast cancer (an aggressive form of the disease).

"We think that if a young woman develops EBV during her teenage years or later, her breast, epithelial cells will be exposed to the virus and can be infected. While for most individuals, there will be no long-term consequences, in some the infection may leave genetic scars and change the metabolism of these cells," explained senior study author Gerburg Wulf, M.D., Ph.D., physician scientist in the hematology/oncology division at BIDMC and associate professor of medicine at Harvard Medical School. "While these are subtle changes, they may decades later, facilitate breast cancer formation."

The researchers feel their findings establish a close link between EBV influencing the development of malignant breast cancer.

“We conclude that a contribution of EBV to breast cancer etiology is plausible, through a mechanism in which EBV infection predisposes mammary epithelial cells to malignant transformation, but is no longer required once malignant transformation has occurred,” the authors stated.

Dr. Wulf added that his team’s findings "further make the case for an EBV vaccine that might protect children from infection and later EBV-associated malignancies."







1087   부모의 특징을 자식에게 전달하는 방식: 박테리아의 DNA  이성욱 2015/02/19 1222
1086   에볼라 확산원인에 대한 새로운 주장  이성욱 2015/01/06 1224
1085   생명과학 연구에서 암컷쥐가 필요한 이유  이성욱 2015/07/23 1226
1084   융합연구리뷰 | Convergence Research Review  이성욱 2016/01/08 1228
1083   인류의 역사를 고스란히 보여주는 결핵균의 게놈  이성욱 2015/01/21 1231
1082   [바이오토픽] 브로드 연구소, 열띤 CRISPR 특허전쟁에서 승리  이성욱 2017/02/16 1235
1081   Gilead wins European approval of next-generation hepatitis C drug  이성욱 2014/11/20 1243
1080   유전자치료제 연구개발 및 규제 동향 2015-식품의약품안전처  이성욱 2016/01/20 1243
1079   Cost to Develop a Drug More Than Doubles to $2.56 Billion  이성욱 2014/11/21 1245
1078   의문이 제기된 `젊은 피`의 항노화 효과  이성욱 2015/05/22 1246
1077   FDA approves 9-valent HPV vaccine for certain cancers  이성욱 2014/12/12 1247
1076   특허전쟁: 미국 특허청, CRISPR의 특허권 중재 시작  이성욱 2016/03/08 1253
1075   Janssen, Isis Pharma Ink Up-to-$835M Antisense Agreement  이성욱 2015/01/07 1255
1074   세계 20여 개국 과학자들, 유전자편집 정상회담 개최  이성욱 2015/12/05 1255
1073   CRISPR의 능력을 배가(倍加)시키는 미니 유전자  이성욱 2015/04/02 1256
1072   정밀의학의 끝: 개인화된 종양백신을 개발하는 과학자들  이성욱 2016/04/26 1259
1071   미국 과학·공학·의학 아카데미, 「GM 베이비」의 진행방향에 대한 윤곽 발표  이성욱 2017/02/16 1261
1070   맹인을 위한 유전자치료의 쇠퇴  이성욱 2015/05/08 1266
1069   줄기세포로 만든 초기 난자와 정자  이성욱 2014/12/31 1267
1068   유전자편집치료에 희망을 준 백혈병치료  이성욱 2015/11/11 1272

[1][2][3][4][5][6][7][8][9] 10 ..[64] [다음 10개]
 

Copyright 1999-2024 Zeroboard / skin by ROBIN